Clinical drug-drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P-glycoprotein (Q47832562)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 August 2014

Language	Label	Description	Also known as
English	Clinical drug-drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P-glycoprotein	scientific article published on 27 August 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

Clinical drug-drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P-glycoprotein (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

drug interaction

1 reference

based on heuristic

inferred from title

author name string

Sarah M Robertson

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

Xia Luo

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

Neeraj Dubey

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

Chonghua Li

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

Ajit B Chavan

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

Geoffrey S Gilmartin

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

Mark Higgins

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

Lisa Mahnke

8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

publication date

27 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

55

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

56-62

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

Cystic fibrosis: a disease of vulnerability to airway surface dehydration.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.377

21 January 2018

Ivacaftor potentiation of multiple CFTR channels with gating mutations

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.377

21 January 2018

Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.377

21 January 2018

Effect of ticagrelor on the pharmacokinetics of ethinyl oestradiol and levonorgestrel in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.377

21 January 2018

Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose study.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.377

21 January 2018

Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.377

21 January 2018

Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.377

21 January 2018

Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.377

21 January 2018

The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.377

21 January 2018

Identifiers

10.1002/JCPH.377

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25103957

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47832562&oldid=2172262505"